Profile of Reactive Estrogen Species in Women with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Bodor, J. N. [1 ]
Krzizike, D. D. [1 ]
Vanderveer, L. [1 ]
Eidbo, S. [1 ]
Zawislak, C. L. [1 ]
Ross, E. A. [1 ]
Andrews, A. J. [2 ]
Edelman, M. J. [1 ]
Treat, J. [1 ]
Clapper, M. L. [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA USA
[2] Univ North Carolina Wilmington, Wilmington, NC USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
EGFR; Reactive Catechols; Estrogen; Metabolism;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA13.04
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [41] EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells
    Giulia M. Stella
    Roberta Scabini
    Simona Inghilleri
    Francesca Cemmi
    Simona Corso
    Ernesto Pozzi
    Patrizia Morbini
    Adele Valentini
    Roberto Dore
    Simona Ferrari
    Maurizio Luisetti
    Michele Zorzetto
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1327 - 1335
  • [42] Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells
    Jiang, Xiao-Ming
    Xu, Yu-Lian
    Huang, Mu-Yang
    Zhang, Le-Le
    Su, Min-Xia
    Chen, Xiuping
    Lu, Jin-Jian
    ACTA PHARMACOLOGICA SINICA, 2017, 38 (11) : 1512 - 1520
  • [43] EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells
    Stella, Giulia M.
    Scabini, Roberta
    Inghilleri, Simona
    Cemmi, Francesca
    Corso, Simona
    Pozzi, Ernesto
    Morbini, Patrizia
    Valentini, Adele
    Dore, Roberto
    Ferrari, Simona
    Luisetti, Maurizio
    Zorzetto, Michele
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1327 - 1335
  • [44] Clinical Characteristics and Continued Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Administration in EGFR-Mutated Non-small Cell Lung Cancer with Skeletal Metastasis
    Hong, Sook-Hee
    Kim, Yeon-Sil
    Lee, Ji Eun
    Kim, In-Ho
    Kim, Seung Joon
    Han, Daehee
    Yoo, Ie Ryung
    Chung, Yang-Guk
    Kim, Young-Hoon
    Lee, Kyo-Young
    Kang, Jin-Hyoung
    CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1110 - 1119
  • [45] Management of EGFR-mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspective
    Cabanero, M.
    Sangha, R.
    Sheffield, B. S.
    Sukhai, M.
    Pakkal, M.
    Kamel-Reid, S.
    Karsan, A.
    Ionescu, D.
    Juergens, R. A.
    Butts, C.
    Tsao, M. S.
    CURRENT ONCOLOGY, 2017, 24 (02) : 111 - 119
  • [46] STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells
    Qian Wang
    Bing Lu
    Yi Zhang
    Jing Yu
    Jie Guo
    Qianchi Zhou
    Hong Lv
    Yifeng Sun
    Human Cell, 2021, 34 : 1855 - 1865
  • [47] STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells
    Wang, Qian
    Lu, Bing
    Zhang, Yi
    Yu, Jing
    Guo, Jie
    Zhou, Qianchi
    Lv, Hong
    Sun, Yifeng
    HUMAN CELL, 2021, 34 (06) : 1855 - 1865
  • [48] Personalized Therapy of Non-small Cell Lung Cancer (NSCLC)
    Gadgeel, Shirish M.
    LUNG CANCER AND PERSONALIZED MEDICINE: NOVEL THERAPIES AND CLINICAL MANAGEMENT, 2016, 890 : 203 - 222
  • [49] Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
    Crintea, Andreea
    Constantin, Anne-Marie
    Motofelea, Alexandru C.
    Crivii, Carmen-Bianca
    Velescu, Maria A.
    Coseriu, Razvan L.
    Ilyes, Tamas
    Craciun, Alexandra M.
    Silaghi, Ciprian N.
    JOURNAL OF FUNCTIONAL BIOMATERIALS, 2023, 14 (09)
  • [50] EGFR Mutation Testing in Non-Small Cell Lung Cancer
    Sriram, Krishna B.
    Francis, Santiyagu M. Savarimuthu
    Tan, Maxine E.
    Bowman, Rayleen V.
    Yang, Ian A.
    Fong, Kwun M.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (04) : 310 - 321
12345